February 7, 2012

Transgene Biotek to sell technology for rh-EPO for US$5mn – India Infoline.com

Transgene Biotek to sell technology for rh-EPO for US$5mn – India Infoline.com


DealCurry
Transgene Biotek to sell technology for rh-EPO for US$5mn
India Infoline.com
Transgene Biotek Ltd, one of the fastest growing biotechnology companies in India announced the sale of technology for recombinant human Erythropoietin (rh-EPO) to TSS EXPORT GmbH FZE, one of the group companies of the TSS Group for US$5.0 million.
Transgene Biotek sells technology for Erythropoietin for $5 millionEquity Bulls


Transgene Biotek to sell biogeneric drug tech to German co for $5 mHindu Business Line
Transgene Biotek Sells Erythropoietin to TSS EXPORT GmbHDealCurry
NASDAQ
all 12 news articles »